Multiplex array proteomics detects increased MMP-8 in CSF after spinal cord injury

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Light, Matthew ^a   Minor, Kenneth H ^a   DeWitt, Peter ^b   Jasper, Kyle H ^a   Davies, Stephen J A ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Biomarker; Cerebrospinal fluid (CSF); Cytokine; Inflammation; Matrix metalloproteinase 8 (MMP 8); Microarray; Proteomics; Spinal cord injury; Tissue inhibitor of metalloproteinase 1 (TIMP 1)

Indexed keywords

CD86 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LEPTIN; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MICROARRAY ANALYSIS; MULTIPLEX ARRAY PROTEOMICS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEOMICS; RAT; SPINAL CORD INJURY; WESTERN BLOTTING;

EID: 84861975522     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-122     Document Type: Article

References (37)

1. National Spinal Cord Injury Statistical Center Spinal cord injury: facts and figures at a glance. J Spinal Cord Med 2005, 28:379-380. National Spinal Cord Injury Statistical Center.
2. Miniño AM. Death in the United States, 2009. NCHS data brief, no. 64 2011, National Center for Health Statistics, Hyattsville, MD, http://www.cdc.gov/nchs/data/databriefs/db64.pdf.
3. van den Berg ME, Castellote JM, de Pedro-Cuesta J, Mahillo-Fernandez I. Survival after spinal cord injury: a systematic review. J Neurotrauma 2010, 27:1517-1528. 10.1089/neu.2009.1138, 20486810.
4. Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD, Pasquale-Styles M, Dietrich WD, Weaver LC. The cellular inflammatory response in human spinal cords after injury. Brain: J Neurol 2006, 129:3249-3269.
5. Leal-Filho MB. Spinal cord injury: from inflammation to glial scar. Surg Neurol Int 2011, 2:112. 10.4103/2152-7806.83732, 3162797, 21886885.
6. Yang L, Jones NR, Blumbergs PC, Van Den Heuvel C, Moore EJ, Manavis J, Sarvestani GT, Ghabriel MN. Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat. J Clin Neurosci 2005, 12:276-284. 10.1016/j.jocn.2004.06.011, 15851082.
7. Blight AR. Macrophages and inflammatory damage in spinal cord injury. J Neurotrauma 1992, 9(Suppl. 1):S83-S91.
8. Pruss H, Kopp MA, Brommer B, Gatzemeier N, Laginha I, Dirnagl U, Schwab JM. Non-Resolving Aspects of Acute Inflammation after Spinal Cord Injury (SCI): Indices and Resolution Plateau. Brain Pathol 2011, 21:652-660. 10.1111/j.1750-3639.2011.00488.x, 21418368.
9. Cohen DM, Patel CB, Ahobila-Vajjula P, Sundberg LM, Chacko T, Liu SJ, Narayana PA. Blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced MRI. NMR Biomed 2009, 22:332-341. 10.1002/nbm.1343, 2741317, 19023867.
10. Ankeny DP, Popovich PG. Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury. Neuroscience 2009, 158:1112-1121. 10.1016/j.neuroscience.2008.07.001, 2661571, 18674593.
11. Fehlings MG, Hawryluk GW. Scarring after spinal cord injury. J Neurosurg Spine 2010, 13:165-167. discussion 167-168, 10.3171/2009.11.SPINE09862, 20672951.
12. Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci 2004, 5:146-156. 10.1038/nrn1326, 14735117.
13. Gensel JC, Donnelly DJ, Popovich PG. Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages. Exp Opin Therapeutic Targets 2011, 15:505-518.
14. Kwon BK, Casha S, Hurlbert RJ, Yong VW. Inflammatory and structural biomarkers in acute traumatic spinal cord injury. Clin Chem Lab Med: CCLM/FESCC 2011, 49:425-433.
15. Reiber H. Cerebrospinal fluid-physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler 1998, 4:99-107.
16. Lee N, Wong CK, Chan PK, Chan MC, Wong RY, Lun SW, Ngai KL, Lui GC, Wong BC, Lee SK, Choi KW, Hui DSC. Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. PLoS One 2011, 6:e26050. 10.1371/journal.pone.0026050, 3192778, 22022504.
17. Mizutani T, Akasaka R, Tomita K, Chiba T. Serial changes of cytokines in Crohn's disease treated with infliximab. Hepatogastroenterol 2011, 58(110-111):1523-1526.
18. Tefferi A, Vaidya R, Caramazza D, Finke C, Lasho T, Pardanani A. Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study. J Clin Oncol 2011, 29:1356-1363. 10.1200/JCO.2010.32.9490, 21300928.
19. Nielsen UB, Geierstanger BH. Multiplexed sandwich assays in microarray format. J Immunol Methods 2004, 290:107-120. 10.1016/j.jim.2004.04.012, 15261575.
20. Pang S, Smith J, Onley D, Reeve J, Walker M, Foy C. A comparability study of the emerging protein array platforms with established ELISA procedures. J Immunol Methods 2005, 302:1-12. 10.1016/j.jim.2005.04.007, 15993890.
21. Benjamini Y, Hochburg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Series B (Methodol) 1995, 57:289-300.
22. Hsueh HM, Chen JJ, Kodell RL. Comparison of methods for estimating the number of true null hypotheses in multiplicity testing. J Biopharm Stat 2003, 13:675-689. 10.1081/BIP-120024202, 14584715.
23. Zhao M, Wang X, Nolte D. Mass-transport limitations in spot-based microarrays. Biomed Opt Express 2010, 1:983-997. 10.1364/BOE.1.000983, 3018043, 21258524.
24. Streit WJ, Semple-Rowland SL, Hurley SD, Miller RC, Popovich PG, Stokes BT. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol 1998, 152:74-87. 10.1006/exnr.1998.6835, 9682014.
25. Wang CX, Olschowka JA, Wrathall JR. Increase of interleukin-1beta mRNA and protein in the spinal cord following experimental traumatic injury in the rat. Brain Res 1997, 759:190-196. 10.1016/S0006-8993(97)00254-0, 9221936.
26. Kwon BK, Stammers AM, Belanger LM, Bernardo A, Chan D, Bishop CM, Slobogean GP, Zhang H, Umedaly H, Giffin M, Street J, Boyd MC, Paquette SJ, Fisher CG, Dvorak MF. Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury. J Neurotrauma 2010, 27:669-682. 10.1089/neu.2009.1080, 20038240.
27. Lubieniecka JM, Streijger F, Lee JH, Stoynov N, Liu J, Mottus R, Pfeifer T, Kwon BK, Coorssen JR, Foster LJ, Grigliatti TA, Tetzlaff W. Biomarkers for severity of spinal cord injury in the cerebrospinal fluid of rats. PLoS One 2011, 6:e19247. 10.1371/journal.pone.0019247, 3084780, 21559420.
28. RayBiotech, Inc http://www.raybiotech.com (November 12, 2011), RayBiotech, Inc.
29. Team RDC. R: A Language and Environment for Statistical Computing 2011, R Foundation for Statistical Computing, Vienna, Austria.
30. Pinheiro J, Bates D, DebRoy S, Sarkar D, . nlme Linear and Nonlinear Mixed Effects Models. R package version 3.1-102 edition 2011, R Foundation for Statistical Computing, Vienna, Austria, nlme.
31. Beck KD, Nguyen HX, Galvan MD, Salazar DL, Woodruff TM, Anderson AJ. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 2010, 133:433-447. 10.1093/brain/awp322, 2858013, 20085927.
32. De Castro RC, Burns CL, McAdoo DJ, Romanic AM. Metalloproteinase increases in the injured rat spinal cord. NeuroReport 2000, 11:3551-3554. 10.1097/00001756-200011090-00029, 11095516.
33. Wells JE, Rice TK, Nuttall RK, Edwards DR, Zekki H, Rivest S, Yong VW. An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J Neurosci 2003, 23:10107-10115.
34. Veeravalli KK, Dasari VR, Tsung AJ, Dinh DH, Gujrati M, Fassett D, Rao JS. Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury. Neurobiol Dis 2009, 36:200-212. 10.1016/j.nbd.2009.07.012, 19631747.
35. Leivonen SK, Chantry A, Hakkinen L, Han J, Kahari VM. Smad3 mediates transforming growth factor-beta-induced collagenase-3 (matrix metalloproteinase-13) expression in human gingival fibroblasts. Evidence for cross-talk between Smad3 and p38 signaling pathways. J Biol Chem 2002, 277:46338-46346. 10.1074/jbc.M206535200, 12270924.
36. Kim ES, Kim MS, Moon A. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol 2004, 25:1375-1382.
37. Cuadrado E, Rosell A, Penalba A, Slevin M, Alvarez-Sabin J, Ortega-Aznar A, Montaner J. Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein array study. J Proteome Res 2009, 8:3191-3197. 10.1021/pr801012x, 19317417.